UNH Stock UnitedHealth Group Incorporated
STRONG BUY US · NYSEDepressed valuation and multiple recent target increases offer recovery potential in managed care.
Future value: $478.12 (+16.42%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Mizuho and Piper Sandler raised price targets.
- ▸Above 50-day MA (+5.65%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (75.2% of range) — strength
Is UNH a buy right now?
Trend: UNH is trading above the 50-day average (+5.65%), RSI 59 — neutral momentum, with a 3-month return of -4.22%.
Valuation & quality: UnitedHealth Group Incorporated trades on a trailing P/E of 26.4, forward P/E 17.6, PEG 1.07, price-to-book 3.56; fundamentals show net margin 3.5%, return on equity 15.8%, revenue growth -0.4% year on year.
Analyst consensus: 25 analysts have a mean 12-month price target of $478.12 (+16.4% vs the last close; range $380.00 – $529.00), consensus rating “buy”.
Income: trailing dividend yield 2.22%.
Our screen: STRONG BUY (score 4) — Depressed valuation and multiple recent target increases offer recovery potential in managed care.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -7.70% | +36.90% | +2.70% | +9.30% | -0.30% | -6.00% | -5.70% | +11.90% |
Fundamentals
Analyst price target
Technical signals
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.
Sector: Healthcare · Industry: Healthcare Plans · United States · 390,000 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.